Novartis (NVS)

Create an Alert
73.12 -0.17  -0.23%   NYSE Jun 18, 5:00PM BATS Real time Currency in USD

Novartis Cash from Investing Quarterly:

696.00M for March 31, 2013
View Full Chart

Novartis Cash from Investing Quarterly Chart

    Novartis Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 696.00M
    Dec. 31, 2012 -2.536B
    Sept. 30, 2012 -1.971B
    June 30, 2012 -723.00M
    March 31, 2012 -445.00M
    Dec. 31, 2011 -824.00M
    Sept. 30, 2011 -569.00M
    June 30, 2011 110.00M
    March 31, 2011 491.00M
    Dec. 31, 2010 -587.00M
    Sept. 30, 2010 -10.66B
    June 30, 2010 -3.371B
    March 31, 2010 -1.136B
    Dec. 31, 2009 -4.193B
    Sept. 30, 2009 -4.452B
    June 30, 2009 -2.732B
    March 31, 2009 -2.842B
    Dec. 31, 2008 -1.729B
    Sept. 30, 2008 -13.12B
    June 30, 2008 1.051B
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
       
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    June 30, 2001 Go Pro
    June 30, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    NVS Cash from Investing Quarterly Benchmarks

    Companies
    Pfizer -10.93B
    Sanofi
    Merck -1.153B

    NVS Cash from Investing Quarterly Rankings

    Overall 99th percentile
    68 of 16773
    Sector 99th percentile
    5 of 1408 in Healthcare
    Industry 97th percentile
    3 of 135 in Drug Manufacturers - Major

    NVS Cash from Investing Quarterly Range, Past 5 Years

    Minimum -13.12B Sep 2008
    Maximum 1.051B Jun 2008
    Average -2.477B

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');